National Trends in the Management of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

被引:0
作者
Joseph T. Mahon
Charles Welliver
机构
[1] Minnesota Urology PA,
[2] Albany Medical Center,undefined
来源
Current Urology Reports | 2020年 / 21卷
关键词
BPH; LUTS; Pharmacotherapy; MIST; Value-based care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 80 条
[1]  
Berry SJ(1984)The development of human benign prostatic hyperplasia with age J Urol 132 474-479
[2]  
Coffey DS(2007)Alpha blockers for the treatment of benign prostatic hyperplasia Rev Urol 9 181-190
[3]  
Walsh PC(2011)Impact of medical therapy on transurethral resection of the prostate: two decades of change BJU Int 108 89-93
[4]  
Ewing LL(2008)Systematic review on recovery specific quality-of-life instruments Surgery. 143 206-215
[5]  
Lepor H(1999)Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults Anesth Analg 88 83-90
[6]  
Izard J(2019)Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis Transl Androl Urol 8 329-338
[7]  
Nickel JC(2015)Benign prostatic hyperplasia: epidemiology, economics and evaluation Can J Urol 22 1-6
[8]  
Kluivers KB(2013)Multi-center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study J Urol 190 2161-2167
[9]  
Riphagen I(2017)Five-year results of the prospective randomized controlled prostatic urethral L.I.F.T. study Can J Urol 24 88028813-775
[10]  
Vierhout ME(2017)Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study BJU Int 119 767-179